Align 科技 ALGN

Joseph M. Hogan Experience: 2015 - Present President and CEO, Align Technology Inc. (dental technology company) Prior CEO, ABB (technology company) Various Positions including CEO of GE Healthcare, General Electric (a medical technology company) Other Board Positions Supervisory Board of avateramedical N.V. (2019-2021) Notable Experience and Key Board Contributions At Align, Mr. Hogan has overseen significant financial and operating performance. Mr. Hogan is a proven leader serving as an integral connection between our board of directors and management. He brings to Align significant leadership experience from large public companies, with strategic business, market development and sales acumen, and expertise in strategic and operational aspects of complex, international organizations. During his five years at ABB, Mr. Hogan oversaw a 25% increase in revenues. As CEO of GE Healthcare, Mr. Hogan drove significant geographic and market portfolio expansion and more than doubled revenues from $7 billion to $16 billion. Education B.S. in Business and Economics from Geneva College M.B.A. from Robert Morris University.

Mr. John F Morici, Principal Accounting Officer, Chief Financial Officer and Executive Vice President, Global Finance - 2022-Present, Chief Financial Officer and Senior Vice President, Global Finance of Align - 2018-2022, Chief Financial Officer of Align - 2016-2018, EVP and Managing Director of NBC Universal North America Home Entertainment - 2014-2016, CFO/Chief Operating Officer of NBC Universal North America Home Entertainment - 2011-2014, Senior Vice President and Chief Financial Officer of NBC Universal North America Home Entertainment - 2007-2011.

Anne M. Myong Experience: 2021 - 2023 President, Amyris, Inc. (biotechnology company) 2020 - 2021 Chief Executive Officer and Chief Financial Officer, Aura Financial (financial services company) 2014 - 2017 Senior Vice President and Chief Financial Officer, Walmart Global eCommerce (eCommerce segment of retail corporation) 2011 - 2014 Senior Vice President, Chief Financial and Administrative Officer, Walmart China Retail (retail corporation) Prior Vice President and Chief Financial Officer, Agilent Technologies China (life science software and supplies company) Other Board Positions Goodwill Industries International, Inc. (2016-2022) Wal-Mart de Mexico, S.A.B. de C.V. (2016-2017) Notable Experience and Key Board Contributions Ms. Myong brings extensive experience in global operations, finance and accounting with a unique knowledge of international markets, a deep understanding of financial reporting and organizational risks, controls and monitoring, and expertise in consumer products, omnichannel retailing, digital marketing, and scaling industry-transforming innovations. As Senior Vice President and Chief Financial Officer of Walmart Global eCommerce, Ms. Myong accelerated the growth, profitability, and digital transformation of Walmart's retail and e-commerce operations in the United States, China, and Brazil. Education B.B.A. in Computer Information Systems from James Madison University M.B.A. from Harvard Business School.

Kevin J. Dallas Experience: 2023 - Present CEO, EnterpriseDB Corporation (software company) 2020 - 2022 CEO, Wind River Systems, Inc. (software company) 1996 - 2020 Corporate Vice President, Cloud & AI Business Development, Microsoft (software company) Prior Various Positions, NVIDIA Corporation and National Semiconductor, now Texas Instruments Inc. (technology company) Other Board Positions EnterpriseDB (2023-present) Notable Experience and Key Board Contributions Mr. Dallas brings more than 25 years of experience driving digital innovation and growth at technology companies and expertise in the digital transformation of customers and partners as well as AI. At Microsoft, Mr. Dallas enabled the digital transformation of customers and partners across a range of industries including: connected/autonomous vehicles, industrial IoT, discrete manufacturing, retail, financial services, media and entertainment, and healthcare. Mr. Dallas has deep expertise in cybersecurity, artificial intelligence, machine learning and information technology. Education B.S.c. in Electrical and Electronic Engineering from Staffordshire University.

Joseph Lacob Experience: 2010 - Present Governor, Co-Executive Chairman and CEO, Golden State Warriors (basketball team) and Golden State WNBA (basketball team) 1987 - 2010 Partner, Kleiner Perkins Caufield & Byers (venture capital firm) Prior Various Positions, Cetus Corporation, now Chiron Corporation (biotechnology company) Various Positions, FHP International (health maintenance organization) Various Positions, Booz, Allen & Hamilton (consulting firm) Other Board Positions Golden State Warriors (2010-present) NeuroPace, Inc. (1997-present) Orexigen Therapeutics, Inc. (2004-2012) Notable Experience and Key Board Contributions Mr. Lacob brings expertise in evaluating and developing strategic opportunities, specifically in the technology, healthcare and life sciences industries. Mr. Lacob also has significant consumer marketing, financial, strategic investment and mergers and acquisition experience. Mr. Lacob was closely involved with KPCB's investments in more than 50 life science companies, including the startup or incubation of a dozen ventures, and with KPCB's medical technology practice, which includes more than 30 therapeutic and diagnostic medical device companies. Education B.S. in Biological Sciences from the University of California at Irvine Masters in Public Health from the University of California at Los Angeles M.B.A. from Stanford University.

Ms. Mojdeh Poul, Experience: 2025 - Present President and Chief Executive Officer, Integra LifeSciences Holdings Corporation (global medical technology company) 2019 - 2022 Executive Vice President and Group President, 3M Healthcare Business Group (global healthcare products company) 2011 - 2018 Various Global Executive Leadership Positions, 3M Healthcare Business Group (global healthcare solutions company) and 3M (diversified global company) 2005 - 2011 Various Global Business Leadership Positions, Medtronic (global medical technology company) Prior Various Marketing Leadership Positions, ev3 (medical device company) Various Global Marketing Leadership Positions, Boston Scientific (global medical technology company) Various Management Positions, Teleflex Medical (global medical device company) Various Engineering Positions, GE Plastics (global engineering plastics company) Other Board Positions Integra LifeSciences Holdings Corporation (2025-Present) CeramTec Advisory Committee (2022-Present) iRhythm Technologies (2023-2025) Stanley Black and Decker (2021-2025) Notable Experience and Key Board Contributions Ms. Poul has 30 years of experience in various segments of the healthcare industry. She has a proven track record of delivering business growth and performance though portfolio transformation, value-creating innovation, and impactful capital allocation. Ms. Poul has deep expertise in corporate strategy, mergers and acquisitions, global profit and loss and operations management, and commercial excellence. Education M.B.A. from the University of North Carolina, Chapel Hill Masters in Mechanical Engineering from the University of Louisville B.S. in Mechanical Engineering from the University of Louisville.

Susan E. Siegel Experience: Ms. Siegel served as Chief Innovation Officer at General Electric from 2017 to 2019, and previously as CEO of GE Ventures and Licensing from 2012 to 2017; prior to that, she was a General Partner at Mohr Davidow Ventures focusing on investments in personalized medicine, life sciences, and digital health, and earlier served as Director and President of Affymetrix. 2017 - 2019 Chief Innovation Officer, GE (conglomerate company) 2012 - 2017 CEO, GE Ventures and Licensing (conglomerate company) Prior General Partner, Mohr Davidow Ventures (multidisciplinary investment firm; Ms. Siegel focused investments in personalized medicine, life sciences and digital health) Director and President, Affymetrix (genomics company) Other Board Positions Illumina, Inc. (2019-present) The Engine (2016-2020), Chair (2020-present) KFF (formerly Kaiser Family Foundation) (2019-present) Nevro Corporation (2020-2025) National Venture Capital Association (2012-2016) Pacific Biosciences, Inc. (2006-2013) Tech Interactive (2003-2007) Affymetrix (2000-2006) Notable Experience and Key Board Contributions Ms. Siegel brings extensive experience in identifying, funding, pioneering, and implementing industry-shifting innovations in the life sciences, biomedical research, and healthcare industries. Ms. Siegel led Affymetrix, one of the fastest growing genomics companies of its time. She led it from a pre-revenue startup to a multi-billion dollar publicly listed company that helped shape the emerging genomics industry, including addressing the bioethical issues of its day. Ms. Siegel has been recognized in Fortune's 34 Leaders Who Are Changing Health Care, as one of The 100 Most Influential Women in Silicon Valley, Fierce Biotech's Top 10 Women in Medical Devices, and was awarded the Lifetime Achievement Award by Global Corporate Venture in 2020. She is an Aspen Institute Henry Crown Fellow and is a featured Multiplier in the bestselling book: Multipliers: How the Best Leaders Make Everyone Smarter. Education B.S. in Biology from the University of Puerto Rico M.S. in Biochemistry and Molecular Biology from Boston University Medical School.